374 results
8-K
EX-99.1
GERN
Geron Corp.
19 Mar 24
Other Events
6:30am
for the same proposed indication, there can be no assurance that we will receive regulatory approval by the FDA or the European Commission … action date for our NDA is June 16, 2024, there can be no assurance as to the timing or outcome of FDA’s ultimate decision on our NDA. The FDA may deny
8-K
EX-3.1
d4n82y6 64q8a
15 Dec 23
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-10.1
5lv zjf8lhx21hkx
2 Nov 23
Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results
8:50am
8-K
EX-5.1
uhqu16z oq4
2 Nov 23
Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results
8:50am
S-8
EX-5.1
2gdsalr571yg8q6bzbg
3 Aug 23
Registration of securities for employees
5:16pm